Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP 3 inflammasome activation in APP/PS 1 transgenic mice

J Feng, JX Wang, YH Du, Y Liu… - CNS neuroscience & …, 2018 - Wiley Online Library
Background Activated microglia‐mediated inflammation plays a key role in the pathogenesis
of Alzheimer's disease (AD). In addition, chronic activation of NLRP 3 inflammasomes …

[HTML][HTML] Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction

WQ Qiu, R Pan, Y Tang, XG Zhou, JM Wu, L Yu… - Biomedicine & …, 2020 - Elsevier
Emerging evidence indicates that the enhancement of microglial autophagy inhibits the
NLRP3 inflammasome mediated neuroinflammation in Alzheimer's disease (AD) …

Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ1-42-induced microglia cells

Y Zhang, Y Zhao, J Zhang, Y Gao, S Li, C Chang… - Neuroscience …, 2021 - Elsevier
Nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3)
inflammasome-mediated chronic neuroinflammation plays a crucial role in the progression …

Resveratrol suppresses Aβ-induced microglial activation through the TXNIP/TRX/NLRP3 signaling pathway

L Feng, L Zhang - DNA and Cell Biology, 2019 - liebertpub.com
Microglia-mediated neuroinflammation plays an important role in Alzheimer's disease
development. Resveratrol, a natural polyphenol from the Japanese knotweed (Polygonum …

[HTML][HTML] Edaravone attenuates the proinflammatory response in amyloid-β-treated microglia by inhibiting NLRP3 inflammasome-mediated IL-1β secretion

HM Wang, T Zhang, JK Huang, JY Xiang… - Cellular Physiology and …, 2017 - karger.com
Background/Aims: Microglial activation is an important pathological feature in the brains of
patients with Alzheimer's disease (AD), and amyloid-β (Aβ) peptides play a crucial role in …

MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease

A Naeem, R Prakash, N Kumari, MA Khan… - Brain, Behavior, and …, 2024 - Elsevier
Alzheimer's disease (AD) is the seventh most common cause of mortality and one of the
major causes of disability and vulnerability in the elderly. AD is characterized by gradual …

The involvement of NLRP3 inflammasome in CUMS-induced AD-like pathological changes and related cognitive decline in mice

JM Li, T Hu, XN Zhou, T Zhang, JH Guo… - Journal of …, 2023 - Springer
Background Numerous studies have found that inhibiting the expression of NLRP3
inflammasome can significantly improve depressive-like behaviors in mice, but the research …

Inhibition of TLR4 induces M2 microglial polarization and provides neuroprotection via the NLRP3 inflammasome in Alzheimer's disease

W Cui, C Sun, Y Ma, S Wang, X Wang… - Frontiers in …, 2020 - frontiersin.org
Accumulating evidence has indicated that activation of microglia and neuroinflammation
reaction play a prominent role in Alzheimer's disease (AD). Inhibition of toll-like receptor 4 …

Punicalagin attenuates LPS-induced inflammation and ROS production in microglia by inhibiting the MAPK/NF-κB signaling pathway and NLRP3 inflammasome …

J Lo, CC Liu, YS Li, PY Lee, PL Liu, PC Wu… - Journal of …, 2022 - Taylor & Francis
Purpose Neurodegenerative diseases are associated with neuroinflammation along with
activation of microglia and oxidative stress, but currently lack effective treatments …

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

L Li, XH Wu, XJ Zhao, L Xu, CL Pan… - Journal of …, 2020 - Springer
Background Alzheimer's disease (AD) is a major clinical problem, but there is a distinct lack
of effective therapeutic drugs for this disease. We investigated the potential therapeutic …